Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

arstechnica.com - Beth Mole - Trump wants Big Pharma to split MMR vaccine; Big Pharma thinks it's idiotic
Trump wants Big Pharma to split MMR vaccine; Big Pharma thinks it's idiotic
Ars Technica

Backlash to Trump's vaccine order on Monday has been swift and sharp, with various public health and medical organizations and independent experts calling it “dangerous,” “ unscientific,” “ false and…

thehindubusinessline.com - 'Not an adjunct to the pharma industry': Medical device representatives seek separate regulatory authority
'Not an adjunct to the pharma industry': Medical device representatives seek separate regulatory authority
BusinessLine

Close to a dozen medical device and civil society organisations, among others, have sought a National Medical Devices Regulatory Authority, with the autonomy of telecom body TRAI or insurance's IRDAI, and regulatory oversight of food authority…

socialmediatoday.com - Andrew Hutchinson - Snapchat ads pharma ad disclaimer links
Snapchat ads pharma ad disclaimer links
Social Media Today

This audio is auto-generated. Please let us know if you have feedback. Snapchat announced a new ad option for pharma marketers on Tuesday. The addition will let pharma advertisers include product disclosure links in their ads, making it easier for…

swissinfo.ch - Jessica Davis Plüss (text) Kai Reusser (visuals) - Basel's world-beating pharma hub fights for place in new global order
Basel's world-beating pharma hub fights for place in new global order
www.swissinfo.ch

Few cities in the world have an identity so tightly bound to an industry as Basel and pharmaceuticals. Roche and Novartis, two of the world's biggest drugmakers, loom large over the city. Walk across any bridge in the city, and you can see the…

swissinfo.ch - swissinfo.ch - Swiss pharma companies flock to North Carolina
Swiss pharma companies flock to North Carolina
www.swissinfo.ch

Mountains, waterfalls, Atlantic beaches – North Carolina's natural beauty is captivating. But that's not why Swiss companies are moving to the state. It is rather thanks to an active investment promotion policy. This policy has become all…

indianexpress.com - Express News Service - Gujarat pharma firm partners held for illegal sale of codeine cough syrup
Gujarat pharma firm partners held for illegal sale of codeine cough syrup
The Indian Express

4 min read Ahmedabad Make us preferred source on Google The Special Operations Group (SOG) of the Ahmedabad City Police has arrested two partners of Ahmedabad-based wholesale pharmaceuticals company on the charge of selling Codeine-based cough…

nhpr.org - Josh Rogers - Warmington defends lobbying work for Purdue Pharma in campaign video
Warmington defends lobbying work for Purdue Pharma in campaign video
New Hampshire Public Radio

Democratic gubernatorial candidate Cinde Warmington has taken to social media to defend her past work as a lobbyist for Purdue Pharma, the maker of Oxycontin. The three-minute video, in which Warmington speaks directly to the camera seated on a…

marketbeat.com - Bank of America Forecasts Strong Price Appreciation for BridgeBio Pharma (NASDAQ:BBIO) Stock
Bank of America Forecasts Strong Price Appreciation for BridgeBio Pharma (NASDAQ:BBIO) Stock
MarketBeat

BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) had its price target raised by equities research analysts at Bank of America from $101.00 to $104.00 in a research report issued to clients and investors on Tuesday, Benzinga reports. The firm…

marketbeat.com - Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA) Given Average Rating of 'Moderate Buy' by Analysts
Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA) Given Average Rating of 'Moderate Buy' by Analysts
MarketBeat

Shares of Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA - Get Free Report) have earned a consensus rating of 'Moderate Buy' from the six research firms that are presently covering the stock, MarketBeat Ratings reports. One investment analyst has…

lionessofjudah.substack.com - Lioness of Judah Ministry - Toby Rogers: Big Pharma's Total Domination and Subversion of Our Republic is Even Worse Than You Think
Toby Rogers: Big Pharma's Total Domination and Subversion of Our Republic is Even Worse Than You Think
Exposing The Darkness

Exposing The Darkness is a reader-supported publication. To support my work, please consider becoming a paid subscriber. One-time or recurring donations can be made through Ko-Fi: ⚡ What aren't they telling you? Please Join Exposing the…

thehill.com - Tara Suter - Carville backing El-Sayed against 'clown' Rogers
Carville backing El-Sayed against 'clown' Rogers
The Hill

Democratic strategist James Carville said he is backing Michigan Democratic Senate candidate Abdul El-Sayed in spite of his criticism of El-Sayed and especially when compared to the Republican in the race. “El-Sayed himself has said the…

seekingalpha.com - Stephen Ayers - AbCellera Biologics: Excellent Data In Menopause But The Platform Narrative Is Fading
AbCellera Biologics: Excellent Data In Menopause But The Platform Narrative Is Fading
Seeking Alpha

AbCellera Biologics has shifted from a pure platform-for-hire to developing its own pipeline, notably ABCL635 for menopausal vasomotor symptoms. ABCL635, a monoclonal antibody targeting NK3R, offers monthly dosing versus daily oral competitors…

ndtv.com - Prateek Shukla - Stock Market LIVE Updates, Sensex Today: Sensex, Nifty Trade Flat Amid Hormuz Deadlock, Asian Markets Mixed
Stock Market LIVE Updates, Sensex Today: Sensex, Nifty Trade Flat Amid Hormuz Deadlock, Asian Markets Mixed
NDTV

Stock Market Live Updates: Indian equity benchmarks opened flat on Wednesday. At the open, Sensex fell 24 points while Nifty was up just 0.75 points. Bodycraft Clinic, a pan-India destination for dermatology, aesthetic medicine and wellness, has…

seekingalpha.com - SA Transcript Insights Editor - Cardinal Health forecasts FY27 EPS of $12.40-$12.60 and at least $1B in share repurchases as board adds $5B to buyback authority (NYSE:CAH)
Cardinal Health forecasts FY27 EPS of $12.40-$12.60 and at least $1B in share repurchases as board adds $5B to buyback authority (NYSE:CAH)
Seeking Alpha

Drivers include strong demand, execution in Pharma/Specialty, and capital returns; risks involve nonrecurring tariff refunds, potential Iran conflict impacts on GMPD, and elevated input costs. The company secured new gene therapy commercialization…

rediff.com - Utkarsh Mishra - Maharashtra: Ayurvedic drug makers under FDA radar
Maharashtra: Ayurvedic drug makers under FDA radar
Rediff.com

The Maharashtra Food and Drug Administration (FDA) has taken stringent action against Ayurvedic drug manufacturers, cancelling the licences of 10 firms and issuing notices to 135 others for serious violations of quality and safety standards. The…

Receive a Daily briefing on Pharma Industry News

Get Started